# An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects With Leukocyte Adhesion Deficiency Type II

> **NCT05754450** · PHASE3 · RECRUITING · sponsor: **AUG Therapeutics** · enrollment: 2 (estimated)

## Conditions studied

- Leukocyte Adhesion Deficiency

## Interventions

- **DRUG:** AVTX-803

## Key facts

- **NCT ID:** NCT05754450
- **Lead sponsor:** AUG Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-10
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 2 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05754450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05754450, "An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects With Leukocyte Adhesion Deficiency Type II". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05754450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*